Dr. Richard Chin | CEO |
Wendy Wee | CFO |
Katja Buhrer | VP of Corporate Development and IR |
Trevor Brown | Stifel |
Ben Haynor | Alliance Global |
Balaji Prasad | Barclays |
Brandon Folkes | Cantor Fitzgerald |
John Lee | H.C. Wainwright |
David Westenberg | Guggenheim Securities |
Welcome to the First Quarter 2021 Financial Results Conference Call and Webcast for Kindred Biosciences. At this time, all participants have been placed on a listen-only mode. At the end of the prepared statements, participants will have the opportunity to ask questions. [Operator Instructions] Please note that remarks made today will include forward-looking statements and that actual results could differ materially from those projected or implied in our forward-looking statements.
For a description of important factors that could cause actual results to differ, we refer you to the forward-looking statements in today's press release and a note on forward-looking statements in the Company's SEC filings.